VP-14637 coidan oral administration of 3-chloro-5-hydroxybenzoic acid

oral administration of 3-chloro-5-hydroxybenzoic acid at 30 mg/kg provided a Cmax of 67 μM at approximately 3-fold over the in vitro EC50 with an AUCinf of 54 h μM and a short t1/2 of 1

Vinconate is an indolonaphthyridine derivative and can stimulate the muscariic acetylcholine receptor

CAS Number: 1062159-35-6

InChi: InChI=1S/C62H71N11O9S2/c1-35(2)54-62(82)72-53(60(80)68-49(55(65)75)30-38-18-22-40-11-4-6-13-42(40)27-38)34-84-83-33-52(71-56(76)46(64)28-37-17-21-39-10-3-5-12-41(39)26-37)61(81)69-50(29-36-19-23-44(74)24-20-36)58(78)70-51(31-43-32-66-47-15-8-7-14-45(43)47)59(79)67-48(16-9-25-63)57(77)73-54/h3-8

and tumor growth is monitored after intra-peritoneal administration of DEL-22379 at 15 mg/kg

VP-14637 coidan oral administration of 3-chloro-5-hydroxybenzoic acidEC50: 5. 4 nM for RSV fusion VP 14637 is an inhibitor of RSV. Respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections in humans. RSV F protein that mediates fusion of the viral envelope with the host cell membrane has become a target of anti RSV treatment. In vitro: Previous study demonstrated that VP 14637 did not block RSV adsorption but inhibited RSV induced cell cell fusion and specifically bound to RSV infected